PsyMed Ventures — Full Portfolio

Ancilia is a biotech company using CRISPR to create beneficial bacterial products, such as live biotherapeutics, that carry immunity against the viruses that destroy them.

BiotechDeep TechHealthtechNew York, US

RBRodolphe Barrangou(Co-founder)inAlex(Co-founder)inDPDavi Paez-Espino(Co-founder)inAlexandra Sakatos(Executive Officer, Director)in

BoardDale Pfost(Director)VSVERA SCHROEDER(Director)in

Co-investorsDEDeep Science VenturesMEMetaplanetSASafar PartnersSNSnatched VenturesSPSpacecadet VenturesMBMBX Capital

Atai Beckley develops rapid-acting, durable, and convenient therapies for mental health conditions where patients currently have limited treatment options.

BiotechDigital HealthMental Health

Co-investorsDADaniel GutenbergNUNucleus Adventure CapitalP5P53 InvestPAPalo Santo VC

AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.

BiotechMedical DevicesMental Health

CAChristian AngermayerCFCosmo Feilding Mellen(Founder)inSRSrinivas Rao

Co-investorsBABailey Venture PartnersFJFJ LabsITIter InvestmentsLELeafy TunnelMAMaiora Rebel VenturesNONoetic+4 more

Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.

BiotechDeep TechDigital HealthSan Diego, US

Co-investorsALALS Investment FundJOJoyance PartnersSOSocial StartsAPApollo Health VenturesLELeaps by Bayer

Bright Minds Biosciences develops selective serotonin receptor agonists (5-HT2A and 5-HT2C) without 5-HT2B activity, built on a proprietary chemistry platform.

BiotechDeep TechHealthtechNew York, US

Alan Kozikowski(Executive Officer, Director)inIan McDonaldRyan Cheung(Chief Financial Officer)JAN PEDERSEN(Chief Science Officer)Gideon Shapiro(Executive Officer)Revati Sheeniwas(Executive Officer)

Co-investorsLILifeSci Venture PartnersPAPalo Santo VC

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)

Co-investorsARArtis VenturesBABailey Venture PartnersCACasa Verde CapitalDODolby Family VenturesGAGaingelsIAIaso Ventures+9 more

Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.

BiotechDigital HealthMental Health

DJDr. John Krystal(Co-founder & CEO)inDBDina Burkitbayeva(Co-founder)in

Co-investorsBEBeni Venture CapitalEVEvolution VC PartnersGAGaingelsITIter InvestmentsLOLongeVCMAManta Ray Ventures+4 more

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

JSJonathan Sporn(Founder)inAKAndrew Kruegel(Founder)inDSDalibor Sames(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Thomas Kevin Murphy, Ph.D.(Executive Officer)JSJONATHAN SPORN(Founder)in

Co-investorsAEAera VCALAlumni VenturesAWAwareness VentureFRFrontera Technology VenturesFRFrontier Path VCGAGaingels+27 more

ImYoo develops a platform that enables continuous, scalable biological data collection from patients outside traditional clinical settings to support precision medicine research and drug development.

BiotechDigital HealthHealthtech

TDTatyana Dobreva(Founder)in

Co-investorsFRFREEFLOW

Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles.

BiotechDeep TechHealthtech

Megan Matthews(Co-founder & President)Megan Blewett(Founder)

Co-investorsVEVenrockUCUCB VenturesDODolby Family Ventures

Jimini Health develops behavioral health solutions using AI and language models for clinically supervised patient care.

AI & Machine LearningDigital HealthMental Health

Bill Hudenko(Chief Clinical Officer)Luis Voloch(Founder)Mark Jacobstein(Founder)Sahil Sud(Founder)

Co-investorsBOBoxGroupCICity LightGRGrove VenturesLILionBirdSCSCB 10XSOSouth Park Commons+1 more

Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.

Digital HealthMedical DevicesMental Health

JSJonathan Sabbagh(Founder)inMBMyriam Barthes(Founder)in

Co-investorsABAble PartnersALAlleyCorpCOCoalition OperatorsFIFifty YearsFJFJ LabsGAGaingels+9 more

Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.

AI & Machine LearningDigital HealthHealthtech

Co-investorsINInnovating CapitalLELeafy Tunnel

Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.

AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US

DDDillan DiNardo(CEO)inTRTom Ray(Founder)inTegan Johnson(Director of Operations)

BoardRand Hindi(Director)in

Co-investorsARARA NEA Ventures (Brand: Dmz.Xyz)BLBlast.ClubEMEmpath VenturesGAGaingelsIMImmeasurableINInitialized Capital+15 more

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

SSSameer Sheth(Founder)inSSSunil Sheth(Founder)NHNick Halper(Chief Operating Officer)inSGSteve Goetz(Chief Technology Officer)inAAAnthony Arnold(Director)inKaiyuan Yang(Founder)

Co-investorsARArboretum VenturesDIDivergent CapitalDODolby Family VenturesFEFeatures Capital HoldingsKDKdT VenturesTMTMC Venture Fund+6 more

Neurode develops a wearable neurostimulation headband paired with a companion app that provides personalized insights and recommendations from psychologists, neuroscientists, and engineers.

AI & Machine LearningDigital HealthHardwareMedical DevicesMental Health

Damian(CTO)

Co-investorsSTStoic VC

Remepy develops "Hybrid Drugs" that combine pharmaceuticals with targeted digital interventions to deliver personalized and adaptive therapies for patients.

AI & Machine LearningBiotechDigital Health

OSOr Shoval(Founder)inAmir Amedi(Founder)Eran Etam(Founder)Michal Tsur(Founder)in

Co-investors9797212 VenturesFRfresh.fundITIT-Farm CorporationM M VenturesNFNFXO.O.G. Venture Partners+5 more

Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases.

BiotechDigital HealthHealthtechMental HealthNew York, US

John Andreadis(Executive Officer, Director)Jan-Anders Karlsson(Executive Officer, Director)Philip Taub(Director)Tim Schlidt(Director)

Co-investorsGAGaingelsITIter Investments

Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.

BiotechDeep TechHealthtech

MBMatthew Baggott(CEO)in

Co-investorsGAGaingelsLELeafy TunnelNONoetic1010X CapitalPAPalo Santo VCWEWefunder

Terran Biosciences is a biotech platform company developing therapeutics and technologies for neurological and psychiatric diseases, including late-stage drug candidates for schizophrenia, psychedelic and empathogen compounds, and an AI-based neuromelanin MRI analysis platform.

AI & Machine LearningBiotechDigital Health

Sam Clark(Chief Executive Officer)Dustin Tetzl(Chief Business Officer)

Co-investorsMAManta International Consultancy S.A.LNONoeticRERed Beard Ventures

TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.

AgTechMental HealthWellness & FitnessVenice, US

NRNanea Reeves(Founder)inZachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)

BoardTim Chang(Director)

Co-investorsBEBeni Venture CapitalBIBitkraft Esports VenturesDEDecentraNetGRGrit Capital PartnersHAHartmann CapitalINIncisive Ventures+7 more